On July 9, 2025, Pacira BioSciences, Inc. reduced its workforce by 71 employees, about 8% of its total staff, to improve manufacturing efficiencies for EXPAREL, aiming for an annual cost reduction of approximately $13 million. The company expects to incur pre-tax charges of $2.4 million to $2.8 million and $5.4 million in accelerated depreciation expenses due to this reduction.